The power of serum albumin levels in predicting mortality in critical patients

Yıl 2024, , 166 - 171, 28.06.2024

Özlem Çakın , Melike Yüce Aktepe

https://doi.org/10.47582/jompac.1482457

Öz

Aims: Given the presence of comorbidities and critical illnesses in patients admitted to the intensive care unit (ICU), it is imperative to accurately forecast their prognosis and mortality in order to effectively plan and administer their therapies. Decreased serum albumin level is associated with adverse clinical outcomes. We designed this study to evaluate the prognostic value of decreased serum albumin level and its association with age in critically ill patients based on data obtained from the intensive care unit (ICU).
Methods: Data of patients followed between June 2022 and December 2023 in the Internal Medicine ICU of Akdeniz University Hospital were retrospectively reviewed. Albumin, C-reactive protein (CRP), Sequential Organ Failure Assessment (SOFA), and Acute Physiology and Chronic Health Evaluation II (APACHE-II) scores were documented within the initial 24 hours following admission to the ICU. Delta Albumin expression was used to express the changes between albumin values. The relationship between the obtained data and age was examined and compared between the surviving and deceased patient groups.
Results: 300 patients were included in the study. Albumin levels were significantly lower at admission compared to discharge in both the survival and deceased groups (both p<0.001). Changes in albumin levels were significantly associated with ICU mortality independently of age, gender, SOFA, and APACHE changes. Lower albumin levels were associated with worse survival (Hazard ratio: 0.80; 95% Confidence interval: 0.69-0.92; p=0.001).
Conclusion: Changes in albumin levels were significantly associated with ICU mortality independently of age, gender, SOFA, and APACHE changes.

Anahtar Kelimeler

Intensive care, Albumin levels, Mortalitiy

Etik Beyan

Prior to the study, approval was obtained from the Akdeniz University Faculty of Medicine Ethics Committee (Decision No: KAEK-274, Annex 1). The study was conducted in accordance with the principles outlined in the Helsinki Declaration.

Kritik hastalarda serum albümin seviyelerinin mortalite öngörüsündeki gücü

Öz

Amaç: Yoğun bakımda (YB) yatan hastaların komorbiditeleri ve kritik durumları göz önüne alındığında, bu hastalar için prognoz ve mortalite prediksiyonu ve buna göre tedavilerinin düzenlenmesi hastalar için hayati önem taşımaktadır. Azalan serum albümin düzeyi (ASA), olumsuz klinik sonuçlarla ilişkilidir. Bu çalışmayı, yoğun bakım ünitesinden (YBÜ) elde edilen verilere dayanarak kritik hastalarda ASA'nin prognostik değerini ve yaşla ilişkisini değerlendirmek için tasarladık.
Gereç ve Yöntem: Akdeniz Üniversitesi Hastanesi Dahiliye YB ünitesinde Haziran 2022- Aralık 2023 tarihleri arasında takip edilen, hastaların verileri retrospektif olarak incelendi. YB kabulden itibaren ilk 24 saat içinde ölçülen Albumin, CRP, SOFA ve APACHE-II skorları kaydedildi. Albumin değerler arasındaki değişimi ifade etmek için Delta Albumin ifadesi kullanıldı. Elde edilen verilerin yaş ile ilişkisine bakıldı, sağ kalan ve kaybedilen hasta gruplarında karşılaştırıldı.
Bulgular: Çalışmaya 300 hasta dahil edildi. Albumin düzeyleri, hem sağkalım grubunda hem de eksitus grubunda çıkışta yatış anına göre anlamlı derecede düşük bulundu ( her ikisi için de p<0,001). Albumin düzeylerindeki değişim yaş, cinsiyet, SOFA ve APACHE değişimlerinden bağımsız olarak yoğun bakım mortalitesi ile anlamlı olarak ilişkili bulundu. Daha düşük albümin seviyeleri, daha kötü sağkalım ile ilişkiliydi (HR:0,80; %95 GA:0,69-0,92 ve p=0,001).
Sonuç: Albumin düzeylerindeki değişim yaş, cinsiyet, SOFA ve APACHE değişimlerinden bağımsız olarak yoğun bakım mortalitesi ile anlamlı olarak ilişkili bulundu.

Anahtar Kelimeler

Yoğun bakım, Albümin seviyesi, Mortalite

Etik Beyan

Çalışma öncesi Akdeniz Üniversitesi Tıp Fakültesi Etik Kurul onayı alındı (Karar No: KAEK-274, Ek 1). Helsinki Bildirgesi’nde belirtilen ilkelere uygun olarak gerçekleştirildi.

Kaynakça

• Pulimood TB, Park GR. Debate: albumin administration should be avoided in the critically ill. Crit Care 2000;4(3):151-155.
• Sudlow G, Birkett DJ, Wade DN. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol. 1975;11(6):824-832.
• Gibbs J, Cull W, Henderson W, Daley J, Hur K, Khuri SF. Preoperative serum albumin level as a predictor of operative mortality and morbidity: results from the National VA Surgical Risk Study. Arch Surg. 1999;134(1):36-42.
• Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gen Med. 2016;9:229-255.
• Peters Jr T. All About Albumin: Biochemistry, Genetics, and Medical Applications. San Diego, CA: Academic Press: 1996.
• Moshage HJ, Janssen JA, Franssen JH, Hafkenscheid JC, Yap SH. Study of the molecular mechanism of decreased liver synthesis of albumin in inflammation. J Clin Invest. 1987;79(6):1635-1641.
• Brenner DA, Buck M, Feitelberg SP, Chojkier M. Tumor necrosis factor-alpha inhibits albumin gene expression in a murine model of cachexia. J Clin Invest. 1990;85(1):248-255.
• Bein T, Unertl K. Möglichkeiten und Grenzen von Score-Systemen in der Intensivmedizin [Potentialities and limitations of the score system in intensive medicine]. Anasthesiol Intensivmed Notfallmed Schmerzther. 1993;28(8):476-483.
• Mutchmore A, Lamontagne F, Chassé M, Moore L, Mayette M. Automated APACHE II and SOFA score calculation using real-world electronic medical record data in a single center. J Clin Monit Comput. 2023;37(4):1023-1033.
• Britt RC, Devine A, Swallen KC, et al. Corticosteroid use in the intensive care unit: at what cost? Arch Surg. 2006;141(2):145-149.
• Corwin HL, Gettinger A, Pearl RG, et al. The CRIT study: anemia and blood transfusion in the critically ill--current clinical practice in the United States. Crit Care Med. 2004;32(1):39-52.
• Ning S, Liu Y, Barty R, et al. The association between platelet transfusions and mortality in patients with critical illness. Transfusion. 2019;59(6):1962-1970.
• Takegawa R, Kabata D, Shimizu K, et al. Serum albumin as a risk factor for death in patients with prolonged sepsis: an observational study. J Crit Care. 2019;51:139-144.
• Tai H, Zhu Z, Mei H, Sun W, Zhang W. Albumin-to-fibrinogen ratio independently predicts 28-day mortality in patients with peritonitis-induced sepsis. Mediators Inflamm. 2020;2020:7280708. doi: 10.1155/2020/7280708
• Han T, Cheng T, Liao Y, et al. Analysis of the value of the blood urea nitrogen to albumin ratio as a predictor of mortality in patients with sepsis. J Inflamm Res. 2022;15:1227.
• Kim MH, Ahn JY, Song JE, et al. The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLoS One. 2015;10(7):e0132109. doi: 10.1371/journal.pone.0132109
• Fleck A, Hawker F, Wallace PI, et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet. 1985;1(8432):781-784.
• Cao Y, Su Y, Guo C, He L, Ding N. Albumin level is associated with short-term and long-term outcomes in sepsis patients admitted in the ICU: a large public database retrospective research. Clin Epidemiol. 2023;15:263-273.
• McCluskey A, Thomas AN, Bowles BJM, Kishen R. The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia, 1996;51(8):724-727.
• Kendall H, Abreu E, Cheng AL. Serum albumin trend is a predictor of mortality in ICU patients with sepsis. Biol Res Nurs. 2019;21(3):237-244.
• Jin X, Li J, Sun L, et al. Prognostic value of serum albumin level in critically ill patients: observational data from large intensive care unit databases. Front Nutr. 2022;9:770674.
• China L, Freemantle N, Forrest E, et al. A randomized trial of albumin infusions in hospitalized patients with cirrhosis. N Engl J Med. 2021;384(9):808-817.
• Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85(4):599-610.
• Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ. 1998;317(7153):235-240.
• Vincent JL, Russell JA, Jacob M, et al. Albumin administration in the acutely ill: what is new and where next? Crit Care. 2014;18(4):231. doi: 10.1186/cc13991